Nicolas Garimano

Nicolas Garimano

Auto-generated profile, based on publicly available information

Nicolas Garimano

Instituto Nacional de Parasitología “Dr. Mario Fatala Chaben” Administración Nacional de Laboratorios e Institutos de Salud Buenos Aires Argentina

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2025 in Photochemistry and Photobiology
Verified
Journal Article
Closed access
NGNicolas Garimano
Nicolas Garimano
TFTaís Aguayo Frías
Taís Aguayo Frías
DMDaniel González Maglio
Daniel González Maglio

1 May 2021 in Journal of Dairy Science
Verified
Journal Article
Closed access
NGN. Garimano
N. Garimano
Ladislao Iván Díaz VergaraLadislao Iván Díaz Vergara
Ladislao Iván Díaz Vergara
AKA.D. Kim
A.D. Kim
EBE.E. Badin
E.E. Badin
SSS. Sodero
S. Sodero
FSFlavia Sacerdoti
Flavia Sacerdoti
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a major etiologic agent that causes bloody diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome (HUS). Shiga toxin (Stx) is the main virulence factor of EHEC responsible for the progression to HUS. Although many laboratories have made efforts to develop an effective treatment for Stx-mediated HUS, a specific therapy has not been found yet. Human consumption of bovine colostrum is known to have therapeutic effects against several gastrointestinal infections because of the peptide and proteins (including antibodies) with direct antimicrobial and endotoxin-neutralizing effects contained in this fluid. We have previously demonstrated that colostrum from Stx type 2 (Stx2)-immunized pregnant cows effectively prevents Stx2 cytotoxicity and EHEC O157:H7 pathogenicity. In this study we evaluated the preservation of the protective properties of hyperimmune colostrum against Stx2 (HIC-Stx2) after pasteurization and spray-drying processes by performing in vitro and in vivo assays. Our results showed that reconstituted HIC-Stx2 colostrum after pasteurization at 60°C for 60 min and spray-dried under optimized conditions preserved specific IgG that successfully neutralized Stx2 cytotoxicity on Vero cells. Furthermore, this pasteurized/dehydrated and reconstituted HIC-Stx2 preserved the protective capacity against EHEC infection in a weaned mice model. The consumption of hyperimmune HIC-Stx2 bovine colostrum could be effective for HUS prevention in humans as well as in EHEC control in calves. However, further studies need to be done to consider its use for controlling EHEC infections.

22 June 2026 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
Daniela Maza VegaDaniela Maza Vega
Daniela Maza Vega
NGNicolás Garimano
Nicolás Garimano
CLCristian Lillo
Cristian Lillo
VNVanesa De Negri
Vanesa De Negri
SASilvia del Valle Alonso
Silvia del Valle Alonso
Jorge MontanariJorge Montanari
Jorge Montanari